Print ISSN:-2581-8112

Online ISSN:-2581-9151

CODEN : IIJOAT

Article History

Received : 28-10-2023

Accepted : 29-11-2023



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 367

PDF Downloaded: 267


Treatment of osteoarthritis knee with bone marrow aspirate concentrate injection


Full Text PDF Share on Facebook Share on Twitter


Original Article

Author Details : Chinmoy Das, Partha Pratim Das, Navonil Gupta, Somesh Saha*

Volume : 9, Issue : 2, Year : 2023

Article Page : 68-73

https://doi.org/10.18231/j.ijor.2023.013



Suggest article by email

Get Permission

Abstract

Aim: To assess the clinical effectiveness and safety of bone marrow aspirate concentrate (BMAC) injections given intraarticularly as a potential treatment for knee osteoarthritis (OA).
Materials and Methods: Data from 60 patients with knee osteoarthritis treated with BMAC injection at a single centre between December 2021 and December 2022 were retrospectively examined. We only included patients with idiopathic osteoarthritis. Post-traumatic osteoarthritis, prior knee surgery, ageless then 50 years or over 85 years, an active infection, uncontrolled diabetes mellitus, rheumatological or another systemic condition, cancer, or immunosuppressive medication use were all exclusion factors.
A single-spin manual approach was used to aspirate and concentrate bone marrow from the iliac crest. The Numeric pain scale (NPS) and Oxford knee score (OKS) were used to evaluate patients both before and after the treatment. A 12-month follow-up period was used.
Results: TThe statistical analysis comprised a total of 60 patients. With a mean age of 67 years (range 50-85), there were 42 females and 18 males. At the end of the follow-up period, the mean NPS reduced from 8.12 to 4.31 (p< 0> Conclusion: A single BMAC intra-articular injection is a dependable and safe technique that improves the clinical condition of knee OA.

Keywords: BMAC intra­articular injection, NPS, OKS



How to cite : Das C, Das P P, Gupta N, Saha S, Treatment of osteoarthritis knee with bone marrow aspirate concentrate injection. IP Int J Orthop Rheumatol 2023;9(2):68-73


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution 4.0 International License, which allows others to remix, and build upon the work, the licensor cannot revoke these freedoms as long as you follow the license terms.